Abstract
A comparison of stage at cancer diagnosis and cancer treatment rates between people with HIV (PWH) and the general US population is needed to identify any disparities by HIV status. We compared 236 PWH in clinical care diagnosed with cancer from 1997 to 2014 to a sample from NCI's Surveillance, Epidemiology and End Results (SEER) Program, presumed to be HIV negative. We performed G-computation using random forest methods to estimate stage and treatment percent differences (PD) by HIV. We conducted sensitivity analyses among non-AIDS-defining cancers (NADC), by sex and by CD4 ≤ 200 or > 200 cells/mm3. PWH were less likely to be diagnosed at localized stage (PD = - 16%; 95% CI - 21, - 11) and more likely to be diagnosed at regional stage (PD = 14%; 95% CI 8, 19) than those in SEER. Cancer treatment rates were 13% lower among PWH as compared to SEER (95% CI - 18, - 8). The difference in percent receiving cancer treatment was more pronounced for those with lower CD4 at cancer diagnosis (PD -15%; 95% CI - 27, - 6). Lower treatment rates were observed among NADC, males, and women with CD4 ≤ 200. Cancer care for PWH could be improved by diagnosis at earlier stages and increasing rates of cancer treatment.
References
Feb 24, 2007·International Journal of Colorectal Disease·Nir WasserbergAndreas M Kaiser
Dec 17, 2010·AIDS·Chad J AchenbachMichael S Saag
Mar 19, 2011·American Journal of Epidemiology·Stijn Vansteelandt, Niels Keiding
Mar 19, 2011·American Journal of Epidemiology·Jonathan M SnowdenKathleen M Mortimer
Apr 13, 2011·Journal of the National Cancer Institute·Meredith S ShielsEric A Engels
Aug 9, 2011·American Journal of Epidemiology·Eric A EngelsJoan L Warren
Mar 16, 2012·Multivariate Behavioral Research·Peter C Austin
Oct 20, 2012·AIDS·Gita SunejaEric A Engels
Jun 15, 2013·American Journal of Public Health·Matthew J MimiagaKenneth H Mayer
Sep 12, 2013·British Journal of Cancer·K SigelJ Wisnivesky
Dec 12, 2013·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Meredith S ShielsEric A Engels
Feb 18, 2014·AIDS and Behavior·Matthew E LevyManya Magnus
Jul 2, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gita SunejaEric A Engels
Aug 12, 2014·AIDS·Todd M GibsonEric A Engels
Nov 27, 2014·AIDS·Marie HellebergNiels Obel
Feb 26, 2015·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Julia L MarcusMichael J Silverberg
Mar 4, 2015·Open Forum Infectious Diseases·Pragna PatelRichard M Novak
Mar 6, 2015·Cancer·Meredith S ShielsEric A Engels
Oct 6, 2015·Annals of Internal Medicine·Michael J SilverbergUNKNOWN North American AIDS Cohort Collaboration on Research and Design of the International Epidemiologic Databases to Evaluate AID
Jul 16, 2016·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Nadia HowladerEric A Engels
May 3, 2019·Cancer·Anna E CoghillMeredith S Shiels